Clinical Trial: Evaluation of SNDX-5613 in Participants With Colorectal Cancer and Other Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Colorectal Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SNDX-5613 in Patients With Colorectal Cancer and Other Solid Tumors
Brief Summary:
This study will evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of SNDX-5613 in participants with colorectal cancer (CRC) or other solid tumors who have failed at least 1 prior line of therapy.
Read more